Concurrent validation of schizotaxia: A pilot study

Biological Psychiatry

Volumn 50, Issue 6, 2001, Pages 434-440

  Stone, William S ^a,b   Faraone, Stephen V ^a,b,c,e   Seidman, Larry J ^a,b,c,e   Green, Alan I ^a   Wojcik, Joanne D ^a   Tsuang, Ming T ^a,b,c,d,e  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^b HARVARD UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Negative symptoms; Neuropsychological deficits; Schizophrenia; Schizotaxia

Indexed keywords

RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENETIC RISK; HUMAN; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PILOT STUDY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RELATIVE; SCHIZOPHRENIA; SCHIZOTAXIA; SUBSTANCE ABUSE; VALIDATION PROCESS;

ADULT; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; TERMINOLOGY;

EID: 0035884534     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01116-7     Document Type: Article

References (40)

1. Schizophrenia, sensory gating, and nicotinic receptors
2. Tables for clinicians to use to convert WAIS-R short forms
3. Hippocampal n-acetyl aspartate in unaffected siblings of patients with schizophrenia: A possible intermediate neurobiological phenotype
4. Reliabilities and intercorrelations of eight measures of proneness to psychosis
5. The continuous Performance Test, Identical Pairs version (CPT-IP): I. New findings about sustained attention in normal families
6. High-risk research: A review of neurobehavioral assessments in offspring of schizophrenic parents
7. Diagnostic accuracy and confusability analyses: An application to the diagnostic interview for genetic studies
8. "Schizotaxia": Clinical implications and new directions for research
9. Diagnostic accuracy and linkage analysis: How useful are schizophrenia spectrum phenotypes?
10. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A diagnostic efficiency analysis
11. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A four-year follow-up study
12. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: The effect of genetic loading
13. Twenty-five year follow-up of the Israeli High-Risk study: Current and lifetime psychopathology
14. The structured interview for schizotypy (SIS): A preliminary report
15. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results form the national comorbidity survey
16. Neuropsychological risk indicators for schizophrenia: A review of family studies
17. Eye tracking and schizophrenia: A selective review
18. Schizotaxia, schizotypy, schizophrenia
19. Diagnostic interview for genetic studies. Rationale, unique features, and training
20. Comorbidity of mental disorders with alcohol and other drug abuse
21. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia
22. An overview of psychiatric disorders in America
23. Eye-tracking dysfunction in offspring from the New York high-risk project: Diagnostic specificity and the role of attention
24. Clinical neuroscience and epidemiology in schizophrenia
25. Functional MRI of attention in relatives of schizophrenic patients
26. A functional magnetic resonance imaging study of auditory vigilance with high and low information processing demands
27. Thalamic and amygdala-hippocampal volume reductions in first degree relatives of schizophrenic patients: An MRI-based morphometric analysis
28. The effect of genetic loading on verbal memory and hippocampal volumes in siblings of patients with schizophrenia
29. Experimental and clinical neuropsychological measures of prefrontal dysfunction in schizophrenia
30. Is attention-deficit hyperactivity disorder in adults a valid disorder?
31. Association of vulnerability markers in relatives of schizophrenic patients
32. Genetic transmission of negative and positive symptoms in the biological relatives of schizophrenics
33. Towards reformulating the diagnosis of schizophrenia
34. Towards the prevention of schizophrenia
35. Treatment of nonpsychotic relatives of patients with schizophrenia: Four case studies
36. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings
37. Assessment of social adjustment by patient self-report